McNeil Expands Recall List

Article

The recall of children's OTC medication began in January with more than 500 lots of products being recalled, and the latest expansion of the recall includes 21 more lots.

McNeil Consumer Healthcare has expanded a recall of its OTC medications to include 21 additional lots. The company said in a news release that the lots were added to as a precautionary measure after a review determined that some packaging materials used in those lots had been shipped and stored on the same type of wooden pallet tied to the presence of 2,4,6-tribromoanisole in earlier recalled lots.

McNeil said it has stopped accepting shipments of materials from its suppliers on that type of pallet.

In January, the company recalled more than 500 lots of its OTC products—including Benadryl, Rolaids, and multiple variations of Motrin, Children's Motrin, Tylenol, and Children's Tylenol—following consumer complaints of moldy, musty or mildew-like odor.

The smell was linked to trace amounts of a chemical called 2,4,6-tribromoanisole, a degradant of 2,4,6-tribromophenol, which is a pesticide and flame retardant used to treat wooden pallets.

McNeil expanded the recall in June to include products it said were inadvertently omitted from the initial action.

For a complete list of the 21 lots in the current recall, click here.

Consumers who purchased products from the recalled lots should stop using the products and contact McNeil for instructions on receiving a refund or replacement, the manufacturer said. Adverse reactions to the products may be reported to the FDA’s MedWatch Program.

Related Videos
Elizabeth Aby, MD | Credit: Minnesota Health Fairview
Video 3 - "Insights Gleaned from Asthma Research for COPD"
Video 3 - "Insights Gleaned from Asthma Research for COPD"
Video 3 - "HIV Treatment: Discussing Adverse Events with Patients"
Prashant Singh, MD | Credit: University of Michigan
Sean Adrean, MD: Impact of Baseline VA on Aflibercept 8 mg Outcomes in DME | Image Credit: Linkedin
Video 3 - "Key Clinical Considerations in HIV Treatment Decisions"
Video 2 - "Lessons from EXPLORER-HCM: Unveiling CMIs' Potential in oHCM Treatment "
Video 1 - "Novel Cardio Myosin Inhibitors Targeting Obstructive Hypertrophic Cardiomyopathy's Root Cause "
© 2024 MJH Life Sciences

All rights reserved.